Prescription Required
Inclusive of all taxes
In Treatment of Constipation Digirest Plus Oral Suspension Mint Sugar Free acts a laxative that helps treat constipation (infrequent bowel movements and hard, dry stools). It works by drawing water into your bowels and making your stools softer and easier to pass. Digirest Plus Oral Suspension Mint Sugar Free also increases the movement of intestines which helps empty your bowels easily. Digirest Plus Oral Suspension Mint Sugar Free reduces the pain and discomfort and improves your quality of life. Digirest Plus Oral Suspension Mint Sugar Free might take 1-2 days to work. Take Digirest Plus Oral Suspension Mint Sugar Free as instructed and do not stop without consulting your doctor. To prevent constipation it is advisable to eat more high-fibre foods including fruit and vegetables and drink plenty of water.
It is unsafe to consume alcohol with Digirest Plus Oral Suspension Mint Sugar Free.
Information regarding the use of Digirest Plus Oral Suspension Mint Sugar Free during pregnancy is not available. Please consult your doctor.
Information regarding the use of Digirest Plus Oral Suspension Mint Sugar Free during breastfeeding is not available. Please consult your doctor.
It is not known whether Digirest Plus Oral Suspension Mint Sugar Free alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Digirest Plus Oral Suspension Mint Sugar Free is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Digirest Plus Oral Suspension Mint Sugar Free may not be needed in these patients. Please consult your doctor.
Digirest Plus Oral Suspension Mint Sugar Free is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Digirest Plus Oral Suspension Mint Sugar Free may not be needed in these patients. Please consult your doctor.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Sun Pharmaceutical Industries Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Enivid lifesciences || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Sitrocs Zenetica India Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Edward Young Labs || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Capto Therapeutics || ₹14.5/tablet (25% cheaper)